Cite Filings / CLDI / 0001641172-25-026066

Feed Companies Filings Check

Sign in

8-K

Current Report

Calidi Biotherapeutics, Inc. Filed 2025-08-29 Acc 0001641172-25-026066

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , form8-k.htm

Around this filing

2025-09-19 8-K Material agreement · Executive or director change
2025-08-29 8-K Regulation FD disclosure
2025-08-27 SCHEDULE 13G Statement of Beneficial Ownership
2025-08-27 3 Initial Statement of Ownership
2025-08-25 4 Director bought 75,000 shares at $2.00 ($150,000)
2025-08-25 4 Chief Executive Officer bought 25,000 shares at $2.00 ($50,000)
2025-08-22 8-K Material agreement · Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading form8-k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…